671 related articles for article (PubMed ID: 26614257)
21. The Role of Testosterone in the Elderly: What Do We Know?
Barone B; Napolitano L; Abate M; Cirillo L; Reccia P; Passaro F; Turco C; Morra S; Mastrangelo F; Scarpato A; Amicuzi U; Morgera V; Romano L; Calace FP; Pandolfo SD; De Luca L; Aveta A; Sicignano E; Trivellato M; Spena G; D'Alterio C; Fusco GM; Vitale R; Arcaniolo D; Crocetto F
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408895
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
23. Androgen deficiency in aging and metabolically challenged men.
Shelton JB; Rajfer J
Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
[TBL] [Abstract][Full Text] [Related]
24. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
[TBL] [Abstract][Full Text] [Related]
25. Testosterone and the aging male: to treat or not to treat?
Bain J
Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
[TBL] [Abstract][Full Text] [Related]
26. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
[TBL] [Abstract][Full Text] [Related]
27. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
28. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
Ko YH; Kim JJ
Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
[TBL] [Abstract][Full Text] [Related]
29. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.
Conners WP; Morgentaler A
Curr Urol Rep; 2013 Dec; 14(6):557-64. PubMed ID: 23999611
[TBL] [Abstract][Full Text] [Related]
30. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
31. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
[TBL] [Abstract][Full Text] [Related]
32. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
33. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
34. Endocrine aspects of sexual dysfunction in men.
Morales A; Buvat J; Gooren LJ; Guay AT; Kaufman JM; Tan HM; Torres LO
J Sex Med; 2004 Jul; 1(1):69-81. PubMed ID: 16422986
[TBL] [Abstract][Full Text] [Related]
35. Male late-onset hypogonadism: pathogenesis, diagnosis and treatment.
Huhtaniemi I; Forti G
Nat Rev Urol; 2011 Apr; 8(6):335-44. PubMed ID: 21502974
[TBL] [Abstract][Full Text] [Related]
36. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
Maganty A; Osterberg EC; Ramasamy R
Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
[TBL] [Abstract][Full Text] [Related]
37. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
38. Testosterone replacement therapy in males with erectile dysfunction.
Jacob BC
J Pharm Pract; 2011 Jun; 24(3):298-306. PubMed ID: 21676853
[TBL] [Abstract][Full Text] [Related]
39. Androgen therapy in the aging male.
Lunenfeld B
World J Urol; 2003 Nov; 21(5):292-305. PubMed ID: 14576959
[TBL] [Abstract][Full Text] [Related]
40. [Testosterone replacement therapy and cardiovascular risk].
Corona G; Dicuio M; Rastrelli G; Sforza A; Maggi M
G Ital Cardiol (Rome); 2017 Nov; 18(11):745-753. PubMed ID: 29105668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]